A perspective on the health care expenditures for defensive medicine

Osti, Michael; Steyrer, Johannes

doi:10.1007/s10198-016-0848-4

Cited by 11 publications

(8 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Beyond DM direct expenses, modelers usually consider indirect costs related to physicians' stress, loss of time and reputation. Litigation may damage physicians' reputations and the huge amount of time spent for claims may lower their productivity [42], which is why physicians may find it convenient to practice DM even when they are fully covered by insurance [43]. Paradoxically, increasing safety in clinical practice may raise patients' expectations excessively in the long run, hence litigation rates too when accidents occur, beyond any significant change in the actual level of DM [6].…”

Section: Estimating Dm and The Economic Impactmentioning

confidence: 99%

“…The most effective reaction to DM, therefore, should be to restore trust with patients, the main source of professional satisfaction for physicians [33]. Since patients who do not trust their physician are reluctant to provide important information [12], communication and respect on both sides needs to be strongly encouraged [42], and physicians should listen to their patients before trying to persuade them [15].…”

Section: Dm Physician-patient Trust and Attitude Toward Clinical Errorsmentioning

confidence: 99%

“…A climate of clinical collaboration would be conducive to the best use of staff in healthcare services [26], eventually cutting DM costs [30]. At the same time, since cooperation between patients and physicians is the social optimum [6,42], continuing efforts are needed to educate patients and their relatives that the most reliable information comes from clinical sources rather than social media [33].…”

Section: Dm Physician-patient Trust and Attitude Toward Clinical Errorsmentioning

confidence: 99%

See 2 more Smart Citations

Defensive medicine in Europe: a ‘full circle’?

Garattini

2020

Eur J Health Econ

View full text Add to dashboard Cite

Section: Estimating Dm and The Economic Impactmentioning

confidence: 99%

Section: Dm Physician-patient Trust and Attitude Toward Clinical Errorsmentioning

confidence: 99%

Section: Dm Physician-patient Trust and Attitude Toward Clinical Errorsmentioning

confidence: 99%

See 1 more Smart Citation

Defensive medicine in Europe: a ‘full circle’?

Garattini

2020

Eur J Health Econ

View full text Add to dashboard Cite

“…Previous studies reported defensive medicine as a major cause of escalating health care costs worldwide. 61,62 Cai et al 63 reported a nation-level study of workplace violence against health care workers in China from 2013 to 2016. They identified 459 criminal cases involving patient-initiated workplace violence against health care workers.…”

Section: Doctor-patient-family Dynamicsmentioning

confidence: 99%

“…Previous studies reported defensive medicine as a major cause of escalating health care costs worldwide. 61 , 62 …”

Section: Doctor-patient-family Dynamicsmentioning

confidence: 99%

Toward the Cure of Acute Lymphoblastic Leukemia in Children in China

Chen

Zhang

Gale

et al. 2021

JCO Global Oncology

View full text Add to dashboard Cite

This study explored results of therapy of children with acute lymphoblastic leukemia (ALL) in China, recent progress, and challenges. Included are a survey of therapy outcomes of ALL in Chinese children nationwide, comparison of these data with global ALL therapy outcomes, analyses of obstacles to improving outcomes, and suggestions of how progress can be achieved. Therapy outcomes at many Chinese pediatric cancer centers are approaching those of resource-rich countries. However, nationwide outcomes still need improvement. Obstacles include suboptimal clinical trials participation, children without adequate health care funding, human resource shortages, especially physicians expert in pediatric hematology and oncology, and social-economic disparities. We suggest how these obstacles have been and continue to be remedied including expanded access to protocol-based therapy, improved supportive care, health care reforms, recruitment of trained personnel, and international collaborations. China has made substantial progress treating children with ALL. We envision even better outcomes in the near future.

show abstract

Defensive medicine in Europe: a ‘full circle’?

Garattini

Padula

2019

Eur J Health Econ

View full text Add to dashboard Cite

A perspective on the health care expenditures for defensive medicine

Cited by 11 publications

References 41 publications

Defensive medicine in Europe: a ‘full circle’?

Defensive medicine in Europe: a ‘full circle’?

Toward the Cure of Acute Lymphoblastic Leukemia in Children in China

Defensive medicine in Europe: a ‘full circle’?

Contact Info

Product

Resources

About